OTC · Medical - Diagnostics & Research

H.U. Group Holdings, Inc. (MRCHF) Stock

$20.05 +1.78% OTC: MRCHF Healthcare

H.U. Group Holdings, Inc., primarily operates in Japan, offering a wide array of laboratory testing products and services through its subsidiaries.

Valuation

MetricValue
Price$20.05
Market Cap$1.11B
P/E Ratio28.31
P/B Ratio1.40
P/S Ratio0.78
EPS (TTM)$0.71
52-Week High$28.06
52-Week Low$18.60
Dividend Yield3.84%

Financials & Margins

MetricValue
ROE5.06%
ROA2.55%
ROCE2.46%
Gross Margin28.82%
Operating Margin1.93%
Net Margin2.76%
Debt/Equity0.54
Current Ratio1.72

Annual Financials (USD)

Metric20222023202420252026
Revenue$272.9B$260.9B$236.9B$243.0B$248.9B
Operating Profit$50.5B$23.4B$-4.0B$2.6B$4.8B
Net Profit$29.6B$15.7B$-7.6B$2.8B$6.9B
EPS$519.42$275.49$-132.77$48.59$121.43
Op Margin18.5%9.0%-1.7%1.1%1.9%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$286.6B$297.9B$290.8B$279.6B$269.1B
Total Liabilities$146.4B$147.9B$148.3B$142.3B$130.8B
Cash$46.5B$44.2B$39.9B$40.9B$48.4B
Borrowings$73.0B$77.2B$81.9B$86.7B$74.8B

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$55.2B$32.5B$16.6B$22.0B$21.7B
Investing Cash Flow$-66.0B$-51.3B$-33.6B$-26.3B$9.0B
Financing Cash Flow$-4.4B$-4.6B$-5.0B$1.8B$-9.3B
Net Cash Flow$3.5B$-2.3B$-4.2B$938.0M$4.9B
Free Cash Flow$20.1B$10.8B$-1.0B$11.7B$19.3B

Valuation & Return Ratios

MetricValue
PEG Ratio0.18
EV / EBITDA7.07
FCF Yield9.94%
Quick Ratio1.39
Interest Coverage6.97
Return 1Y-9.30%
Return 3Y12.15%
Return 5Y—

Ownership

Insiders Held0.02%
Institutions Held62.10%
Institutions Float Held62.11%
Institutional HolderSharesReport Date
Datum One Series Trust-BRANDES INTERNATIONAL SMALL CAP EQUITY FUND1,503,6002026-03-31
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund818,7042026-04-30
GMO TRUST-GMO-Usonian Japan Value Creation Fund598,2002026-05-31
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund526,9532026-03-31
iShares Trust-iShares Core MSCI EAFE ETF349,6002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About H.U. Group Holdings, Inc.

H.U. Group Holdings, Inc., primarily operates in Japan, offering a wide array of laboratory testing products and services through its subsidiaries. Its service portfolio encompasses diagnostic testing for healthcare facilities, self-medication support, analytical services for the food, environmental, and cosmetic sectors, and testing provisions for corporate health insurance associations. The group also engages in the research, development, manufacturing, and sale of in vitro diagnostic (IVD) equipment. This portfolio features the LUMIPULSE, an automated chemiluminescent enzyme immunoassay system delivering reagents for detecting infectious diseases, various cancers, and lifestyle-related conditions to both medical institutions and diagnostic centers. They also produce ESPRINE, a line of rapid diagnostic kits for conditions like influenza, hepatitis B, and the novel coronavirus. Furthermore, the company supplies essential ingredients for pharmaceutical test drugs. The group further extends its offerings to include administrative support for hospitals, providing aid for surgical and endoscope room operations, medical equipment inspection and maintenance, and in-hospital logistics and transportation management. Additionally, it is involved in the rental and sale of nursing-care equipment and supplies, as well as delivering home-visit nursing care services. Founded in 1950 and based in Tokyo, Japan, the company operated as Miraca Holdings Inc. until July 2020, when it rebranded to H.U. Group Holdings, Inc.

H.U. Group Holdings, Inc. is headquartered in JP.

H.U. Group Holdings, Inc. (MRCHF) stock trades at $20.05 with a market capitalization of $1.11B. The stock is valued at a price-to-earnings (P/E) ratio of 28.31, price-to-book of 1.40, price-to-sales of 0.78. Over the past 52 weeks the stock has ranged between $18.60 and $28.06, and currently trades 28.5% below its 52-week high. It pays a dividend yielding 3.84%.

On profitability, H.U. Group Holdings, Inc. generates a return on equity (ROE) of 5.06%, return on capital employed of 2.46%, an operating margin of 1.93%, a net profit margin of 2.76%.

Official website: www.hugp.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides